PUBLICATION
Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish
- Authors
- Volgin, A.D., Yakovlev, O.A., Demin, K.A., Alekseeva, P.A., Kalueff, A.V.
- ID
- ZDB-PUB-181027-14
- Date
- 2018
- Source
- Behavioural brain research 359: 274-280 (Journal)
- Registered Authors
- Kalueff, Allan V.
- Keywords
- Scopolamine, anxiety, atropine, deliriant hallucinogens, locomotion, zebrafish
- MeSH Terms
-
- Animals
- Animals, Outbred Strains
- Anxiety/chemically induced
- Atropine/pharmacology*
- Behavior, Animal/drug effects*
- Dose-Response Relationship, Drug
- Female
- Hallucinogens/pharmacology*
- Male
- Models, Animal
- Motor Activity/drug effects
- Random Allocation
- Scopolamine/pharmacology*
- Zebrafish*
- PubMed
- 30366034 Full text @ Behav. Brain Res.
Citation
Volgin, A.D., Yakovlev, O.A., Demin, K.A., Alekseeva, P.A., Kalueff, A.V. (2018) Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish. Behavioural brain research. 359:274-280.
Abstract
Atropine and scopolamine are classical muscarinic cholinergic antagonists that exert multiple CNS effects. Belonging to a group of deliriant hallucinogens, these drugs induce delirium-like hallucinations, hyperactivity, altered affective states and amnesia. However, as deliriants remain the least studied group of hallucinogens, their complex and poorly understood profiles necessitate further clinical and preclinical studies. The zebrafish (Danio rerio) is rapidly emerging as a powerful model organism for translational neuropsychopharmacology research. Here, we characterize acute behavioral effects of atropine (60, 90 and 120 mg/L) and scopolamine (60, 120, 180 and 240 mg/L) in adult zebrafish novel tank (NTT), light-dark (LDT) and shoaling tests. Overall, atropine at 90 mg/L only mildly increased the NTT locomotor activity, scopolamine at 120 mg/L produced anxiogenic-like NTT effects without affecting other behaviors, and both drugs similarly disrupted zebrafish group behavior in the shoaling test. Collectively, this supports partially overlapping deliriant-like effects of acute atropine and scopolamine in zebrafish. The behavioral sensitivity to these drugs suggests zebrafish as potential screens for cholinergic deliriant psychotropic drugs, also necessitating further cross-species in-vivo experimental studies.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping